Anthropic даёт гранты до $50 000 в кредитах Claude на исследования редких болезней

Anthropic opened a thematic call for proposals within its AI for Science program on July 20, 2026, focused on rare genetic diseases: selected researchers will receive up to $50000 in Claude credits for six months of work.

What participants get

Anthropic is allocating up to $50000 in Claude credits to each approved project for a term of six months. This is the company's first thematic call within the broader AI for Science program — previously, applications were accepted across any scientific field.

The program is split into two tracks: one for scientists conducting fundamental research, and the other for early-stage biotech startups accelerating the clinical development of treatments for rare diseases.

• Application start date — July 20, 2026
• Grant — up to $50000 in Claude credits for 6 months
• Two tracks: fundamental science and early-stage biotech startups
• Scale of the problem — about 400 million people and more than 7000 rare diseases
• Early partner — the Monarch Initiative consortium

Why rare diseases are hard to study

Taken together, rare diseases are among the most common conditions on the planet: according to the estimate cited by Anthropic, about 400 million people live with one of more than 7000 such diseases. But each one affects a small population, which makes it difficult for clinicians to build patient registries, identify promising therapeutic targets, and plan clinical trials.

Anthropic also points to a second challenge — isolation. Each rare disease is described through unique features (a specific genetic mutation or set of symptoms) that are studied separately from others, which makes it almost impossible to spot shared mechanisms between diseases. The company believes AI helps model such diseases and find patterns across many of them at once, as well as synthesize insights from a large body of literature.

Why the Monarch Initiative matters

The program's early partner is the Monarch Initiative, an international consortium that improves diagnosis and the search for mechanisms behind rare diseases. Monarch develops the Mondo Disease Ontology — a computational system that unifies disease definitions from OMIM, Orphanet, ICD, and dozens of other sources — as well as the Monarch Knowledge Graph.

Monarch recently assembled a new "agent-friendly" library called DisMech: Claude reads clinical case reports, genetic variant databases, registry schemas, and raw open data, and points to mechanistic similarities between diseases at a speed previously unattainable. The consortium invites Anthropic's grantees to use these resources and add to them.

"Our goal is to bring together a community of researchers studying how AI can change our understanding of rare diseases,"

Anthropic's blog states.

What this means

Anthropic is shifting the AI for Science program from scattered individual projects to thematic waves. The company is betting that several teams working on related questions and sharing findings will make faster progress than each would alone.

Frequently Asked Questions

How much does the grant provide?

Each approved project receives up to $50000 in Claude credits for a term of six months. This is not a cash payment but access to the Anthropic API.

Who can apply?

Applications are accepted along two tracks: scientists conducting fundamental research into the mechanisms of rare diseases, and early-stage biotech startups accelerating clinical development.

What is the AI for Science program?

Anthropic launched AI for Science in spring 2025 to accelerate scientific discovery through access to its API. Projects already supported include drug repurposing and quantum modeling.